These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 16626297

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Reprogramming RelA.
    Campbell KJ, Perkins ND.
    Cell Cycle; 2004 Jul; 3(7):869-72. PubMed ID: 15190199
    [Abstract] [Full Text] [Related]

  • 3. Regulation and function of IKK and IKK-related kinases.
    Häcker H, Karin M.
    Sci STKE; 2006 Oct 17; 2006(357):re13. PubMed ID: 17047224
    [Abstract] [Full Text] [Related]

  • 4. Good cop, bad cop: the different faces of NF-kappaB.
    Perkins ND, Gilmore TD.
    Cell Death Differ; 2006 May 17; 13(5):759-72. PubMed ID: 16410803
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Role of NF-kappaB in p53-mediated programmed cell death.
    Ryan KM, Ernst MK, Rice NR, Vousden KH.
    Nature; 2000 Apr 20; 404(6780):892-7. PubMed ID: 10786798
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A mechanistic study of the proapoptotic effect of tolfenamic acid: involvement of NF-κB activation.
    Jeong JB, Yang X, Clark R, Choi J, Baek SJ, Lee SH.
    Carcinogenesis; 2013 Oct 20; 34(10):2350-60. PubMed ID: 23784084
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Aberrant rel/nfkb genes and activity in human cancer.
    Rayet B, Gélinas C.
    Oncogene; 1999 Nov 22; 18(49):6938-47. PubMed ID: 10602468
    [Abstract] [Full Text] [Related]

  • 12. Role of the NF-kappaB pathway in the pathogenesis of human disease states.
    Yamamoto Y, Gaynor RB.
    Curr Mol Med; 2001 Jul 22; 1(3):287-96. PubMed ID: 11899077
    [Abstract] [Full Text] [Related]

  • 13. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
    Dong QG, Sclabas GM, Fujioka S, Schmidt C, Peng B, Wu T, Tsao MS, Evans DB, Abbruzzese JL, McDonnell TJ, Chiao PJ.
    Oncogene; 2002 Sep 19; 21(42):6510-9. PubMed ID: 12226754
    [Abstract] [Full Text] [Related]

  • 14. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
    de Oliveira KA, Kaergel E, Heinig M, Fontaine JF, Patone G, Muro EM, Mathas S, Hummel M, Andrade-Navarro MA, Hübner N, Scheidereit C.
    Genome Med; 2016 Mar 17; 8(1):28. PubMed ID: 26988706
    [Abstract] [Full Text] [Related]

  • 15. Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-kappaB transactivation.
    Campbell KJ, Witty JM, Rocha S, Perkins ND.
    Cancer Res; 2006 Jan 15; 66(2):929-35. PubMed ID: 16424027
    [Abstract] [Full Text] [Related]

  • 16. Yangonin blocks tumor necrosis factor-α-induced nuclear factor-κB-dependent transcription by inhibiting the transactivation potential of the RelA/p65 subunit.
    Ma J, Liang H, Jin HR, Dat NT, Zhang SY, Jiang YZ, Nan JX, Li D, Wu X, Lee JJ, Jin X.
    J Pharmacol Sci; 2012 Jan 15; 118(4):447-54. PubMed ID: 22510965
    [Abstract] [Full Text] [Related]

  • 17. NF-kappaB in cardiovascular disease: diverse and specific effects of a "general" transcription factor?
    Jones WK, Brown M, Wilhide M, He S, Ren X.
    Cardiovasc Toxicol; 2005 Jan 15; 5(2):183-202. PubMed ID: 16046793
    [Abstract] [Full Text] [Related]

  • 18. Cross talk between stimulated NF-kappaB and the tumor suppressor p53.
    Schneider G, Henrich A, Greiner G, Wolf V, Lovas A, Wieczorek M, Wagner T, Reichardt S, von Werder A, Schmid RM, Weih F, Heinzel T, Saur D, Krämer OH.
    Oncogene; 2010 May 13; 29(19):2795-806. PubMed ID: 20190799
    [Abstract] [Full Text] [Related]

  • 19. NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death.
    Zheng Y, Ouaaz F, Bruzzo P, Singh V, Gerondakis S, Beg AA.
    J Immunol; 2001 Apr 15; 166(8):4949-57. PubMed ID: 11290773
    [Abstract] [Full Text] [Related]

  • 20. NF-kappaB activation and inhibition: a review.
    Sun Z, Andersson R.
    Shock; 2002 Aug 15; 18(2):99-106. PubMed ID: 12166787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.